|Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.||
Science and Shams
Shaywitz, a practicing physician, contends that the growing controversy over corporate involvement in medical research is much ado about nothing. Shaywitz further argues that industry involvement in medical research is critical because of the extraordinary costs of drug development.
While fraud itself is fortunately quite rare in science, you still shouldn't believe everything you read. It turns out that the scientific literature is characterized by a shockingly high rate of irreproducibility, often estimated to exceed 50 percent. A review of this subject last year in the journal PLOS-Medicine by Dr. John Ioannidis became an instant cult classic.
|home spotlight commentary research events news about contact links archives|